Skip to main content
Erschienen in: Head and Neck Pathology 1/2015

01.03.2015 | Proceedings of the North American Society of Head and Neck Pathology Companion Meeting, March 22, 2015, Boston, Massachusetts

IgG4 Related Disease of the Head and Neck

verfasst von: Vikram Deshpande

Erschienen in: Head and Neck Pathology | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

IgG4 related disease of the head and neck region represents one of the more common manifestations of IgG4 related disease. Involvement of the submandibular and parotid glands, the orbit and thyroid represent some of the more common sites involved by IgG4 related disease. Eosinophilic angiocentric fibrosis, Mikulicz disease and Riedel thyroiditis are also members of the family of IgG4 related disease. Clinically, the disease is characterized by tumefactive lesions, often multicentric, that show a swift response to immunosuppressive therapy. An elevated serum IgG4 represents the only validated blood based biomarker. However, elevated serum IgG4 is detected in only half the patients with this disease. Histology continues to represent the gold standard for the diagnosis of IgG4 related disease: storiform-type fibrosis and obliterative phlebitis constitute characteristic features of this disease. A definitive diagnosis of IgG4 related disease also requires the presence of elevated numbers of IgG4 positive plasma cells as well as an IgG4 to IgG ratio of greater than 40 %. In isolation, elevated numbers of IgG4 positive plasma cells represents a non-specific feature, detected in a variety of other inflammatory as well as neoplastic diseases. Attention to the clinical context, histological features, as well as an elevated IgG4 to IgG ratio is critical to avoiding overdiagnosis of IgG4 related disease.
Literatur
1.
Zurück zum Zitat Mahajan VS, Mattoo H, Deshpande V, et al. IgG4-related disease. Annu Rev Pathol. 2014;9:315–47.CrossRefPubMed Mahajan VS, Mattoo H, Deshpande V, et al. IgG4-related disease. Annu Rev Pathol. 2014;9:315–47.CrossRefPubMed
2.
Zurück zum Zitat Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181–92.CrossRefPubMed Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181–92.CrossRefPubMed
3.
Zurück zum Zitat Li Y, Zhou G, Ozaki T, et al. Distinct histopathological features of Hashimoto’s thyroiditis with respect to IgG4-related disease. Mod Pathol. 2012;25:1086–97.CrossRefPubMed Li Y, Zhou G, Ozaki T, et al. Distinct histopathological features of Hashimoto’s thyroiditis with respect to IgG4-related disease. Mod Pathol. 2012;25:1086–97.CrossRefPubMed
4.
Zurück zum Zitat Deshpande V, Huck A, Ooi E, et al. Fibrosing variant of Hashimoto thyroiditis is an IgG4 related disease. J Clin Pathol. 2012;65:725–8.CrossRefPubMed Deshpande V, Huck A, Ooi E, et al. Fibrosing variant of Hashimoto thyroiditis is an IgG4 related disease. J Clin Pathol. 2012;65:725–8.CrossRefPubMed
5.
6.
Zurück zum Zitat Della-Torre E, Mattoo H, Mahajan VS, et al. IgG4-related midline destructive lesion. Ann Rheum Dis. 2014;73:1434–6.CrossRefPubMed Della-Torre E, Mattoo H, Mahajan VS, et al. IgG4-related midline destructive lesion. Ann Rheum Dis. 2014;73:1434–6.CrossRefPubMed
7.
Zurück zum Zitat Stone JH. IgG4-related disease: nomenclature, clinical features, and treatment. Semin Diagn Pathol. 2012;29:177–90.CrossRefPubMed Stone JH. IgG4-related disease: nomenclature, clinical features, and treatment. Semin Diagn Pathol. 2012;29:177–90.CrossRefPubMed
8.
Zurück zum Zitat Deshpande V. The pathology of IgG4-related disease: critical issues and challenges. Semin Diagn Pathol. 2012;29:191–6.CrossRefPubMed Deshpande V. The pathology of IgG4-related disease: critical issues and challenges. Semin Diagn Pathol. 2012;29:191–6.CrossRefPubMed
9.
Zurück zum Zitat Mattoo H, Mahajan VS, Della-Torre E, et al. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol. 2014;134:679–87.CrossRefPubMed Mattoo H, Mahajan VS, Della-Torre E, et al. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol. 2014;134:679–87.CrossRefPubMed
10.
Zurück zum Zitat Wallace ZS, Mattoo H, Carruthers M, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015;74(1):190–5.CrossRefPubMed Wallace ZS, Mattoo H, Carruthers M, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015;74(1):190–5.CrossRefPubMed
12.
Zurück zum Zitat Ferry JA, Deshpande V. IgG4-related disease in the head and neck. Semin Diagn Pathol. 2012;29:235–44.CrossRefPubMed Ferry JA, Deshpande V. IgG4-related disease in the head and neck. Semin Diagn Pathol. 2012;29:235–44.CrossRefPubMed
13.
Zurück zum Zitat Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol. 2010;34:1812–9.CrossRefPubMed Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol. 2010;34:1812–9.CrossRefPubMed
14.
Zurück zum Zitat Kitagawa S, Zen Y, Harada K, et al. Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (Kuttner’s tumor). Am J Surg Pathol. 2005;29:783–91.CrossRefPubMed Kitagawa S, Zen Y, Harada K, et al. Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (Kuttner’s tumor). Am J Surg Pathol. 2005;29:783–91.CrossRefPubMed
15.
16.
Zurück zum Zitat Geyer JT, Ferry JA, Harris NL, et al. Chronic sclerosing sialadenitis (Kuttner tumor) is an IgG4-associated disease. Am J Surg Pathol. 2010;34:202–10.CrossRefPubMed Geyer JT, Ferry JA, Harris NL, et al. Chronic sclerosing sialadenitis (Kuttner tumor) is an IgG4-associated disease. Am J Surg Pathol. 2010;34:202–10.CrossRefPubMed
17.
Zurück zum Zitat Deshpande V, Chicano S, Finkelberg D, et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol. 2006;30:1537–45.CrossRefPubMed Deshpande V, Chicano S, Finkelberg D, et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol. 2006;30:1537–45.CrossRefPubMed
18.
Zurück zum Zitat Stone JH, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64:3061–7.CrossRefPubMed Stone JH, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64:3061–7.CrossRefPubMed
19.
20.
Zurück zum Zitat Yamamoto M, Takahashi H, Ohara M, et al. A new conceptualization for Mikulicz’s disease as an IgG4-related plasmacytic disease. Mod Rheumatol. 2006;16:335–40.CrossRefPubMedCentralPubMed Yamamoto M, Takahashi H, Ohara M, et al. A new conceptualization for Mikulicz’s disease as an IgG4-related plasmacytic disease. Mod Rheumatol. 2006;16:335–40.CrossRefPubMedCentralPubMed
21.
Zurück zum Zitat Deshpande V, Khosroshahi A, Nielsen GP, et al. Eosinophilic angiocentric fibrosis is a form of IgG4-related systemic disease. Am J Surg Pathol. 2011;35:701–6.CrossRefPubMed Deshpande V, Khosroshahi A, Nielsen GP, et al. Eosinophilic angiocentric fibrosis is a form of IgG4-related systemic disease. Am J Surg Pathol. 2011;35:701–6.CrossRefPubMed
22.
Zurück zum Zitat Wallace ZS, Deshpande V, Stone JH. Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review. Semin Arthritis Rheum. 2014;43:806–17.CrossRefPubMed Wallace ZS, Deshpande V, Stone JH. Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review. Semin Arthritis Rheum. 2014;43:806–17.CrossRefPubMed
23.
Zurück zum Zitat Kakudo K, Li Y, Taniguchi E, et al. IgG4-related disease of the thyroid glands. Endocr J. 2012;59:273–81.CrossRefPubMed Kakudo K, Li Y, Taniguchi E, et al. IgG4-related disease of the thyroid glands. Endocr J. 2012;59:273–81.CrossRefPubMed
24.
Zurück zum Zitat Li Y, Nishihara E, Kakudo K. Hashimoto’s thyroiditis: old concepts and new insights. Curr Opin Rheumatol. 2011;23:102–7.CrossRefPubMed Li Y, Nishihara E, Kakudo K. Hashimoto’s thyroiditis: old concepts and new insights. Curr Opin Rheumatol. 2011;23:102–7.CrossRefPubMed
25.
Zurück zum Zitat Kakudo K, Li Y, Hirokawa M, et al. Diagnosis of Hashimoto’s thyroiditis and IgG4-related sclerosing disease. Pathol Int. 2011;61:175–83.CrossRefPubMed Kakudo K, Li Y, Hirokawa M, et al. Diagnosis of Hashimoto’s thyroiditis and IgG4-related sclerosing disease. Pathol Int. 2011;61:175–83.CrossRefPubMed
26.
Zurück zum Zitat Li Y, Nishihara E, Hirokawa M, et al. Distinct clinical, serological, and sonographic characteristics of hashimoto’s thyroiditis based with and without IgG4-positive plasma cells. J Clin Endocrinol Metab. 2010;95:1309–17.CrossRefPubMed Li Y, Nishihara E, Hirokawa M, et al. Distinct clinical, serological, and sonographic characteristics of hashimoto’s thyroiditis based with and without IgG4-positive plasma cells. J Clin Endocrinol Metab. 2010;95:1309–17.CrossRefPubMed
27.
Zurück zum Zitat Sah RP, Chari ST. Clinical hypothyroidism in autoimmune pancreatitis. Pancreas. 2010;39:1114–6.CrossRefPubMed Sah RP, Chari ST. Clinical hypothyroidism in autoimmune pancreatitis. Pancreas. 2010;39:1114–6.CrossRefPubMed
28.
Zurück zum Zitat Dahlgren M, Khosroshahi A, Nielsen GP, et al. Riedel’s thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res (Hoboken). 2010;62:1312–8.CrossRef Dahlgren M, Khosroshahi A, Nielsen GP, et al. Riedel’s thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res (Hoboken). 2010;62:1312–8.CrossRef
29.
Zurück zum Zitat Bartholomew LG, Cain JC, Woolner LB, et al. Sclerosing cholangitis: its possible association with Riedel’s struma and fibrous retroperitonitis. Report of two cases. N Engl J Med. 1963;269:8–12.CrossRefPubMed Bartholomew LG, Cain JC, Woolner LB, et al. Sclerosing cholangitis: its possible association with Riedel’s struma and fibrous retroperitonitis. Report of two cases. N Engl J Med. 1963;269:8–12.CrossRefPubMed
30.
Zurück zum Zitat Reder L, Della-Torre E, Stone JH, et al. Clinical manifestations of IgG4-related disease in the pharynx: case series and review of the literature. Ann Otol Rhinol Laryngol. 2014;0003489414549574. Reder L, Della-Torre E, Stone JH, et al. Clinical manifestations of IgG4-related disease in the pharynx: case series and review of the literature. Ann Otol Rhinol Laryngol. 2014;0003489414549574.
31.
Zurück zum Zitat Kobraei EM, Song TH, Mathisen DJ, et al. Immunoglobulin g4-related disease presenting as an obstructing tracheal mass: consideration of surgical indications. Ann Thorac Surg. 2013;96:e91–3.CrossRefPubMed Kobraei EM, Song TH, Mathisen DJ, et al. Immunoglobulin g4-related disease presenting as an obstructing tracheal mass: consideration of surgical indications. Ann Thorac Surg. 2013;96:e91–3.CrossRefPubMed
Metadaten
Titel
IgG4 Related Disease of the Head and Neck
verfasst von
Vikram Deshpande
Publikationsdatum
01.03.2015
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 1/2015
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-015-0620-6

Weitere Artikel der Ausgabe 1/2015

Head and Neck Pathology 1/2015 Zur Ausgabe

Proceedings of the North American Society of Head and Neck Pathology Companion Meeting, March 22, 2015, Boston, Massachusetts

Approach to Metastatic Carcinoma of Unknown Primary in the Head and Neck: Squamous Cell Carcinoma and Beyond

Proceedings of the North American Society of Head and Neck Pathology Companion Meeting, March 22, 2015, Boston, Massachusetts

Mutant Allele Tumor Heterogeneity (MATH) and Head and Neck Squamous Cell Carcinoma

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …